Evaluation of preoperative endoscopic pyloric dilation for prevention of postoperative pyloric stenosis after Ivor-Lewis-esophagectomy

Not Applicable

Recruiting

• Conditions: C15; K31; Malignant neoplasm of oesophagus; Other diseases of stomach and duodenum

• Registration Number: DRKS00028044
• Lead Sponsor: Elisabeth-Krankenhaus Essen, Abteilung für Gastroenterologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

age >18 years, written consent, intended Ivor-Lewis-esophagectomy due to esophageal carcinoma, benign tumours oder functional disease.

Exclusion Criteria

age < 18 years, pregnancy, no written consent, patients with pyloroplastic or G-POEM of the pylorus, esophageal stenosis.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eed for postoperative endoscopic pyloric dilation and number of repetions in the first 2 months.

Secondary Outcome Measures

Name	Time	Method
Technical success, complication rate for bleeding, Perforation and pneumonia, rate of anastomotic leakage, anastomotic stenosis, need for surgical pyloroplastic, need for inpatient treatment.